Lex Diagnostics Limited
Explore this company’s associated devices, FDA decisions and regulatory history.

Lex Diagnostics Limited
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Lex Diagnostics Limited. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Feb 13, 2026 to Feb 13, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QOF appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Melbourn Science Park, Melbourn, SG8 6EE, GB. Recorded on K251742, decision dated Feb 13, 2026.
Device categories in this collection
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
VELO Respiratory TestK251742 | Lex Diagnostics Limited | 510(k) clearance | Feb 13, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
